ARIAD Pharma (ARIA) Shares Continue Lower as Feuerstein Piece Highlighted
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/22/2026
- Nasdaq reaches record high close, AI stocks rally
- Meta AI agent triggers heavy selloff in banks, insurers, and travel stocks
- Exclusive: SB Energy Nasdaq IPO moving forward as planned
- AI and earnings keep driving markets as focus shifts to Trump-Xi summit
- Meta bull case increasingly playing out, Mizuho says
- Pennsylvania measles cases near 800 as outbreak grows
- A timeline of Trump administration moves to weaken endangered species protections
- Meta AI agent ‘Muse’ triggers massive tech rally as chips and Wall Street soar
- Nasdaq notches record-high close, AI optimism reignites and Treasury yields retreat
- SpaceX and Tesla’s AI linkup is getting deeper. Here’s what Morgan Stanley sees
ARIAD Pharma (ARIA) puts active after former presidential candidate Senator Bernie Sanders posted to Twitter
October 14, 2016 1:53 PM EDTARIAD Pharma (NASDAQ: ARIA) October weekly 12.5 and 13 puts are active on total put volume of 2,500 contracts (900 calls) on former presidential candidate Senator Bernie Sanders posted to Twitter: "Drug corporations' greed is unbelievable. Ariad has raised the price of a leukemia drug to almost $199,000 a... More
ARIAD Pharma (ARIA) Criticized in Tweet by Bernie Sanders
October 14, 2016 1:43 PM EDT(Updated - October 14, 2016 1:50 PM EDT)
Shares of ARIAD Pharma (NASDAQ: ARIA) plunged Friday following a tweet by Senator and former presidential hopeful Bernie Sanders. Sanders tweeted a STAT article from Oct. 7th discussing an increase in the price of ARIAD's leukemia drug,... More
